...
首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >New animal models for encapsulating peritoneal sclerosis--role of acidic solution.
【24h】

New animal models for encapsulating peritoneal sclerosis--role of acidic solution.

机译:封装腹膜硬化的新动物模型-酸性溶液的作用

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Encapsulating peritoneal sclerosis (EPS), in which all or part of the intestine is enveloped in a fibrous ball resembling a cocoon, is a serious complication of peritoneal dialysis (PD). The aim of the present study was to investigate whether pH-neutral or acidic dialysis solutions induce peritoneal fibrosis. DESIGN: We divided 18 male Wistar-Kyoto (WKY) rats into three groups and dialyzed them with various solutions as follows: group I, 10 mL acidic dialysis solution (pH 3.8, containing 1.35% glucose), n = 6; group II, 10 mL pH 5.0 dialysis solution, n = 6; and group III, 10 mL neutral dialysis solution (pH 7.0), n = 6. Peritoneal catheters were inserted, and dialysis solution was injected every day for 40 days. At the end of the experiment, a peritoneal equilibration test (PET) was performed. Expression of mRNA of aquaporins 1 and 4 (AQP-1 and AQP-4) in the peritoneum were studied by semiquantitative reverse-transcriptase polymerase chain reaction (RT-PCR). RESULTS: In rats treated with pH 3.8 dialysis solution, necropsy findings revealed features identical to those of EPS. The typical appearance was of granulation tissue or fibrotic tissue (or both) covering multiple surfaces. Multiple adhesions were present. In microscopic examinations, peritoneal fibrosis and loss of mesothelium were found. In rats treated with pH 7.0 dialysis solution, no signs of EPS were seen. In rats treated with pH 5.0 dialysis solution, milder changes (subserosal thickening and partial adhesion of the peritonea) were observed. The mRNA of AQP-1 and AQP-4 were expressed in the peritonea of the rats. The expression of the AQPs was significantly suppressed in rats treated with pH 3.8 dialysis solution. CONCLUSIONS: In rats, long-term intraperitoneal injection of acidic dialysis solution produced features typical of EPS in humans. Newly developed neutral dialysis solutions protected the against the development of EPS during peritoneal dialysis in rats.
机译:目的:将全部或部分肠包封在类似茧的纤维球中的腹膜硬化(EPS)是严重的腹膜透析(PD)并发症。本研究的目的是研究pH中性或酸性透析溶液是否引起腹膜纤维化。设计:我们将18只雄性Wistar-Kyoto(WKY)大鼠分为三组,并用以下各种溶液透析:I组,10 mL酸性透析溶液(pH 3.8,含1.35%葡萄糖),n = 6;第二组,10 mL pH 5.0透析液,n = 6;第三组为10 mL中性透析液(pH 7.0),n =6。插入腹膜导管,每天注射透析液40天。在实验结束时,进行了腹膜平衡测试(PET)。通过半定量逆转录酶聚合酶链反应(RT-PCR)研究了水通道蛋白1和4(AQP-1和AQP-4)的mRNA在腹膜中的表达。结果:在用pH 3.8透析液治疗的大鼠中,尸检发现的特征与EPS相同。典型的外观是肉芽组织或纤维化组织(或两者)覆盖多个表面。存在多次粘连。在显微镜检查中,发现腹膜纤维化和间皮丢失。在用pH 7.0透析液治疗的大鼠中,未观察到EPS的迹象。在用pH 5.0透析液治疗的大鼠中,观察到较轻的变化(浆膜下增厚和部分腹膜粘连)。 AQP-1和AQP-4的mRNA在大鼠腹膜中表达。在用pH 3.8透析液处理的大鼠中,AQPs的表达被显着抑制。结论:在大鼠中,长期腹膜内注射酸性透析溶液可产生人类典型的EPS特征。新开发的中性透析溶液可防止大鼠腹膜透析过程中EPS的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号